Cargando…

Germline genetic testing in prostate cancer – further enrichment in variant histologies?

Detalles Bibliográficos
Autores principales:	Markowski, Mark C., Antonarakis, Emmanuel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978447/ https://www.ncbi.nlm.nih.gov/pubmed/29854870 http://dx.doi.org/10.18632/oncoscience.403

Ejemplares similares

AR Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Antonarakis, Emmanuel S.
Publicado: (2018)

Germline testing and genetic counselling in prostate cancer
por: Russo, Jessica, et al.
Publicado: (2022)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
por: Antonarakis, Emmanuel S.
Publicado: (2018)

Rucaparib for metastatic castration-resistant prostate cancer: did TRITON3 deliver a trifecta?
por: Elias, Roy, et al.
Publicado: (2023)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
por: Crocetto, Felice, et al.
Publicado: (2021)

Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss
por: Markowski, Mark C., et al.
Publicado: (2022)

Germline Variants of Prostate Cancer in Japanese Families
por: Hayano, Takahide, et al.
Publicado: (2016)

Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer
por: Cheng, Heather H., et al.
Publicado: (2023)

Bipolar androgen therapy (BAT): A patient's guide
por: Denmeade, Samuel, et al.
Publicado: (2022)

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020)

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management
por: Doan, David K., et al.
Publicado: (2021)

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
por: Nguyen-Dumont, Tú, et al.
Publicado: (2021)

Glioma: interaction of acquired and germline genetics
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2021)

Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer
por: Herold, Natalie, et al.
Publicado: (2023)

Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease
por: Saunders, Edward J., et al.
Publicado: (2021)

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies
por: Sfanos, Karen S., et al.
Publicado: (2018)

Germline pathogenic variants in unselected Korean men with prostate cancer
por: So, Min-Kyung, et al.
Publicado: (2022)

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion
por: Trivellin, Giampaolo, et al.
Publicado: (2023)

Current progress and questions in germline genetics of prostate cancer
por: Isaacs, William B., et al.
Publicado: (2019)

CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
por: Adib, Elio, et al.
Publicado: (2021)

Androgen Receptor Variant–Driven Prostate Cancer II: Advances in Laboratory Investigations
por: Lu, Changxue, et al.
Publicado: (2020)

Towards Automation of Germline Variant Curation in Clinical Cancer Genetics
por: Ravichandran, Vignesh, et al.
Publicado: (2019)

Genetic and Chemical Effects on Somatic and Germline Aging
por: Lee, Myon-Hee, et al.
Publicado: (2020)

Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia
por: Douglas, Suvi P. M., et al.
Publicado: (2022)

Welcome to PathoGenetics
por: Ballabio, Andrea, et al.
Publicado: (2008)

Copy number variants in absence epilepsy: Further complications of the picture
por: Depondt, Chantal
Publicado: (2016)

Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy
por: Akamatsu, Shusuke, et al.
Publicado: (2022)

Applying comprehensive histologic assessment and genetic testing to synchronous multifocal lung adenocarcinomas and further survival analysis
por: Xiao, Fei, et al.
Publicado: (2019)

Further Association of Germline CHEK2 Loss-of-Function Variants with Testicular Germ Cell Tumors
por: Kirchner, Kira, et al.
Publicado: (2023)

Disparities in germline testing among racial minorities with prostate cancer
por: Weise, Nicole, et al.
Publicado: (2021)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

Germline TTN variants are enriched in PTEN-wildtype Bannayan–Riley–Ruvalcaba syndrome
por: Yehia, Lamis, et al.
Publicado: (2017)

Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma
por: Maciaszek, Jamie L., et al.
Publicado: (2019)

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
por: Lotan, Tamara L., et al.
Publicado: (2021)

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer
por: Pavanello, Marina, et al.
Publicado: (2020)

Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer
por: Goyal, Jatinder, et al.
Publicado: (2013)

PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date
por: Nizialek, Emily, et al.
Publicado: (2020)

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants
por: Dias, Alexander, et al.
Publicado: (2023)

Advanced Science–Growing Further and Further
por: Severing, Kirsten
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_spaicb0m6qjvdpm5p9lokc3e9u